ADAMTS13 and thrombotic thrombocytopenic purpura: Regular plasma transfusions can help prevent acute TTP attacks and fetal growth retardation in such cases.[7] The risk of recurrence in patients with acquired TTP and severe ADAMTS13 deficiency during pregnancy is uncertain and may range from 0% to 50%.[1,7]